Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials.

King CR, Collins S, Fuller D, Wang PC, Kupelian P, Steinberg M, Katz A.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):939-45. doi: 10.1016/j.ijrobp.2013.08.019. Epub 2013 Oct 9.

PMID:
24119836
[PubMed - indexed for MEDLINE]
Free Article
2.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.

PMID:
23497695
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.

Katz A, Ferrer M, Suárez JF; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Radiat Oncol. 2012 Nov 20;7:194. doi: 10.1186/1748-717X-7-194.

PMID:
23164305
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1043-8. doi: 10.1016/j.ijrobp.2008.05.059. Epub 2008 Aug 26.

PMID:
18755555
[PubMed - indexed for MEDLINE]
5.

Potency preservation following stereotactic body radiation therapy for prostate cancer.

Obayomi-Davies O, Chen LN, Bhagat A, Wright HC, Uhm S, Kim JS, Yung TM, Lei S, Batipps GP, Pahira J, McGeagh KG, Collins BT, Kowalczyk K, Bandi G, Kumar D, Suy S, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Nov 1;8:256. doi: 10.1186/1748-717X-8-256.

PMID:
24180317
[PubMed - indexed for MEDLINE]
Free Article
6.

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.

Bhattasali O, Chen LN, Woo J, Park JW, Kim JS, Moures R, Yung T, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2014 Feb 11;9:52. doi: 10.1186/1748-717X-9-52.

PMID:
24512837
[PubMed - in process]
Free PMC Article
7.

Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.

King CR, Brooks JD, Gill H, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):877-82. doi: 10.1016/j.ijrobp.2010.11.054. Epub 2011 Feb 6.

PMID:
21300474
[PubMed - indexed for MEDLINE]
8.

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.

Ju AW, Wang H, Oermann EK, Sherer BA, Uhm S, Chen VJ, Pendharkar AV, Hanscom HN, Kim JS, Lei S, Suy S, Lynch JH, Dritschilo A, Collins SP.

Radiat Oncol. 2013 Jan 31;8:30. doi: 10.1186/1748-717X-8-30.

PMID:
23369294
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer.

Quon H, Cheung PC, Loblaw DA, Morton G, Pang G, Szumacher E, Danjoux C, Choo R, Kiss A, Mamedov A, Deabreu A.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):617-23. doi: 10.1016/j.ijrobp.2011.07.005. Epub 2011 Nov 11.

PMID:
22079736
[PubMed - indexed for MEDLINE]
10.

Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial.

Wiegner EA, King CR.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):442-8. doi: 10.1016/j.ijrobp.2009.07.1748. Epub 2010 Feb 4.

PMID:
20137864
[PubMed - indexed for MEDLINE]
11.

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

Jereczek-Fossa BA, Beltramo G, Fariselli L, Fodor C, Santoro L, Vavassori A, Zerini D, Gherardi F, Ascione C, Bossi-Zanetti I, Mauro R, Bregantin A, Bianchi LC, De Cobelli O, Orecchia R.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):889-97. doi: 10.1016/j.ijrobp.2010.11.031. Epub 2011 Jan 27.

PMID:
21277113
[PubMed - indexed for MEDLINE]
12.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032. Epub 2013 Oct 15.

PMID:
24139077
[PubMed - indexed for MEDLINE]
13.

Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.

Pinkawa M, Piroth MD, Holy R, Fischedick K, Klotz J, Székely-Orbán D, Eble MJ.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):23-8. doi: 10.1016/j.ijrobp.2010.05.054. Epub 2010 Sep 9.

PMID:
20832182
[PubMed - indexed for MEDLINE]
14.

Stereotactic body radiotherapy for organ-confined prostate cancer.

Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M.

BMC Urol. 2010 Feb 1;10:1. doi: 10.1186/1471-2490-10-1.

PMID:
20122161
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

Kupelian PA, Reddy CA, Klein EA, Willoughby TR.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):988-93.

PMID:
11704322
[PubMed - indexed for MEDLINE]
16.

A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.

Oermann EK, Slack RS, Hanscom HN, Lei S, Suy S, Park HU, Kim JS, Sherer BA, Collins BT, Satinsky AN, Harter KW, Batipps GP, Constantinople NL, Dejter SW, Maxted WC, Regan JB, Pahira JJ, McGeagh KG, Jha RC, Dawson NA, Dritschilo A, Lynch JH, Collins SP.

Technol Cancer Res Treat. 2010 Oct;9(5):453-62.

PMID:
20815416
[PubMed - indexed for MEDLINE]
Free Article
17.

Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.

Jereczek-Fossa BA, Santoro L, Zerini D, Fodor C, Vischioni B, Dispinzieri M, Bossi-Zanetti I, Gherardi F, Bonora M, Caputo M, Vavassori A, Cambria R, Garibaldi C, Cattani F, Matei DV, Musi G, De Cobelli O, Orecchia R.

J Urol. 2013 Jun;189(6):2099-103. doi: 10.1016/j.juro.2013.01.005. Epub 2013 Jan 9.

PMID:
23313200
[PubMed - indexed for MEDLINE]
18.

Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

Ball AJ, Gambill B, Fabrizio MD, Davis JW, Given RW, Lynch DF, Shaves M, Schellhammer PF.

J Endourol. 2006 Oct;20(10):723-31.

PMID:
17094746
[PubMed - indexed for MEDLINE]
19.

Stereotactic body radiotherapy as boost for organ-confined prostate cancer.

Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M.

Technol Cancer Res Treat. 2010 Dec;9(6):575-82.

PMID:
21070079
[PubMed - indexed for MEDLINE]
Free Article
20.

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.

Quon H, Cheung PC, Loblaw DA, Morton G, Pang G, Szumacher E, Danjoux C, Choo R, Thomas G, Kiss A, Mamedov A, Deabreu A.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):898-905. doi: 10.1016/j.ijrobp.2010.11.003. Epub 2011 Jan 14.

PMID:
21237581
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk